Skip to main content

Table 3 Average SF-36 subscale scores and effect sizes for the study groups at first and final follow-up*

From: Magnitude and meaningfulness of change in SF-36 scores in four types of orthopedic surgery

SF-36 scores

Total hip replacement

(controls)

Total hip replacement

(patients)

Total knee

replacement

Arthroscopic partial

meniscectomy

Anterior cruciate

ligament

reconstruction

  

N

M (SD)

ES

N

M (SD)

ES

N

M (SD)

ES

N

M (SD)

ES

N

M (SD)

ES

PF

Baseline

44

79.6 (17.7)

 

147

30.7 (20.1)

 

68

30.0 (14.9)

 

62

59.0 (21.8)

 

46

44.2 (21.8)

 
 

First follow-up

44

78.2 (21.8)

-0.1

147

60.5 (22.0)

1.5

68

60.6 (21.1)

2.1

62

73.7 (21.9)

0.7

46

79.6 (17.7)

1.6

 

Final follow-up

44

74.5 (24.1)

-0.3

147

57.6 (27.3)

1.3

68

52.3 (24.1)

1.5

   

46

83.4 (20.2)

1.8

RP

Baseline

42

68.5 (41.0)

 

139

8.5 (20.2)

 

64

12.6 (23.7)

 

62

36.7 (38.3)

 

46

14.1 (26.7)

 
 

First follow-up

42

69.6 (42.6)

0.0

139

49 (42.6)

2.0

64

42.7 (42.4)

1.3

62

62.5 (42.2)

0.7

46

64.7 (40.0)

1.9

 

Final follow-up

42

60.1 (42.4)

-0.2

139

49.6 (43.2)

2.0

64

48.0 (43.9)

1.5

   

46

80.4 (34.9)

2.5

BP

Baseline

50

75.7 (24.2)

 

154

30.9 (17.2)

 

66

30.6 (18.8)

 

62

44.4 (19.2)

 

46

41.8 (20.4)

 
 

First follow-up

50

73.0 (27.6)

-0.1

154

70.3 (23.6)

2.3

66

70.9 (23.7)

2.1

62

63.3 (24.9)

1.0

46

74.4 (20.7)

1.6

 

Final follow-up

50

70.2 (28.0)

-0.2

154

67.1 (26.0)

2.1

66

63.9 (25.1)

1.8

   

46

75.8 (25.3)

1.7

GH

Baseline

46

70.2 (20.3)

 

139

68.8 (19.1)

 

59

66.0 (18.3)

 

61

82.4 (15.1)

 

46

81.5 (15.8)

 
 

First follow-up

46

68.6 (22.0)

-0.1

139

72.5 (20.7)

0.2

59

70.0 (20.9)

0.2

61

80.1 (19.4)

-0.2

46

85.0 (15.8)

0.2

 

Final follow-up

46

61.8 (22.7)

-0.4

139

63.6 (22.9)

-0.3

59

62.7 (24.0)

-0.2

   

46

83.4 (17.1)

0.1

VT

Baseline

45

69.8 (21.7)

 

135

50.9 (20.1)

 

59

50.3 (26.7)

 

62

60.8 (22.1)

 

46

59.5 (19.3)

 
 

First follow-up

45

69.1 (21.6)

0.0

135

70.9 (19.2)

1.0

59

67.3 (24.4)

0.6

62

69.4 (22.3)

0.4

46

71.6 (22.5)

0.6

 

Final follow-up

45

63.8 (22.6)

-0.3

135

64.3 (22.4)

0.7

59

61.0 (27.7)

0.4

   

46

72.1 (20.0)

0.7

SF

Baseline

49

87.8 (19.7)

 

157

65.4 (26.2)

 

66

72.7 (23.0)

 

62

86.3 (18.6)

 

46

72.6 (26.0)

 
 

First follow-up

49

84.9 (18.9)

-0.1

157

87.9 (19.5)

0.9

66

86.7 (19.1)

0.6

62

87.5 (22.6)

0.1

46

90.8 (16.1)

0.7

 

Final follow-up

49

82.7 (24.0)

-0.3

157

84.3 (22.3)

0.7

66

83.5 (25.2)

0.5

   

46

94.3 (14.6)

0.8

RE

Baseline

37

76.1 (34.4)

 

139

39.3 (43.6)

 

56

40.5 (43.0)

 

62

68.8 (38.1)

 

46

52.9 (43.6)

 
 

First follow-up

37

76.6 (37.6)

0.0

139

68.1 (39.7)

0.7

56

64.0 (43.1)

0.5

62

77.4 (36.6)

0.2

46

81.9 (36.3)

0.7

 

Final follow-up

37

77.5 (40.9)

0.0

139

65.5 (42.0)

0.6

56

57.7 (42.4)

0.4

   

46

92.0 (20.1)

0.9

MH

Baseline

45

86.6 (13.7)

 

136

69.8 (21.6)

 

59

71.0 (21.0)

 

62

78.1 (18.4)

 

46

71.8 (18.9)

 
 

First follow-up

45

85.2 (13.9)

-0.1

136

83.8 (17.7)

0.6

59

80.0 (19.7)

0.4

62

83.6 (17.6)

0.3

46

84.3 (17.0)

0.7

 

Final follow-up

45

82.0 (15.6)

-0.3

136

80.6 (17.9)

0.5

59

77.2 (20.1)

0.3

   

46

86.2 (12.8)

0.8

  1. *Note: First follow-up was three months for APM and six months for THR, TKR, and ACL groups; Final follow-up was five years for THR and TKR groups and two years for ACL.
  2. PF = Physical Functioning, RP = Role Physical, BP = Bodily Pain, GH = General Health, VT = Vitality, SF = Social Functioning, RE = Role Emotional, MH = Mental Health.